Point72 Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-100,000
Closed -$710K 1022
2017
Q3
$710K Sell
100,000
-1,452,700
-94% -$10.3M ﹤0.01% 651
2017
Q2
$11.2M Buy
1,552,700
+1,452,700
+1,453% +$10.5M 0.06% 304
2017
Q1
$616K Buy
+100,000
New +$616K ﹤0.01% 674
2014
Q3
Sell
-1,247,000
Closed -$19.2M 778
2014
Q2
$19.2M Buy
+1,247,000
New +$19.2M 0.12% 200